Leukemia e matla ea Lymphoblastic (T-ALL)-08

Yesheng oa Fujian o itse, "Hoja ke ne ke tseba ka CAR-T ho BIOOCUS Medical Group, nka be ke tlile pejana."

Ka Loetse 2017, Yesheng o ile a ba le makhopho a sefahlehong, a ileng a ata butle-butle mme a kopana le dibaka. Ka la 28 Hlakola 2018, tlhahlobo ya moko wa masapo e tiisitse "leukemia e matla ya T-cell lymphoblastic" kamora dithuto tse ngata tsa chemotherapy, ka diteko tse sa feleng tse salang. Meriana yohle e ile ya emiswa ka Phuptjane 2019.

Ka Mots'eanong 2021, Yesheng o ile a hlaheloa ke bongata sebakeng sa molomo le pharyngeal le li-lymph node tse atolositsoeng tsa molala. Tlhahlobo e ncha ea moko oa masapo e tiisitse ho khutla hape ka botlalo ha leukemia. Ka la 28 Mots'eanong, Yesheng o ile a fetisetsoa Lefapheng la Bobeli la Hematology bakeng sa kamohelo. Kamora litlhahlobo tse felletseng, tlhahlobo e ile ea fetoloa ho ba "leukemia e matla (T/myeloid biphenotypic)."

Potoloho e le 'ngoe ea chemotherapy ha ea ka ea baka pholiso mokong oa masapo. Ka la 27 Phupu, Yesheng o ile a fuoa pheko ea lisele tsa CD7 CAR-T, ea lateloa ke chemotherapy e kopantsoeng le phekolo ea lisele tsa CD7 CAR-T tsa autologous. Matsatsi a leshome le metso e mehlano kamora pheko, tlhahlobo ea moko oa masapo e bontšitse lefu le setseng le lebe, ka karabelo ea cytokine release syndrome (CRS) ea sehlopha sa 1 'me ha ho na liphello tse mpe tsa tsamaiso ea methapo ea bohareng.